Endpoints News
OpenLoop buys nutrition startup Read in browser
Endpoints News
Tuesday, 7 April 2026
Thank you for reading, dupa dupackia!
basic
UPGRADE
TOP R&D TRENDS IN 2026:
John Carroll’s R&D 15 report is back — and this year, he’s bringing some of the industry’s top research chiefs into the conversation to break down what the data means, what’s shifting, and where biopharma R&D is headed. Join us to find out what comes next.
Rise of megarounds
Health tech kicked off the year with a series of eye-popping funding rounds. 
Whoop raised a $575 million Series G last week. Others, like OpenEvidence, eMed, Talkiatry and Alphabet's Verily all raised rounds of $200 million or more.
It’s a familiar story to the one we saw play out at the start of last year. But this time, the numbers are even higher. 
Total funding in the first quarter of 2026 hit $4 billion across 110 deals — $1 billion more than the same time last year, according to digital health consultancy Rock Health. There haven't been this many nine-figure checks in a quarter since 2022, the report said.
But the funds are still only going toward a small slice of health tech. A number of early- and mid-stage startups are still struggling to raise, while 59% of all funding this past quarter went into just 12 megadeals. 
What I’m more interested in is how these megarounds mask another dynamic. Startups are staying private longer and raising larger late-stage funding rounds instead of going public. Plenty of companies have said they are eyeing an IPO, but only Hinge Health and Omada Health have made the leap. 
Still, the health tech industry can't afford to stay private forever. It's just a question of who dares go next.
- Ngai
Here’s what’s new
Exclusive: OpenLoop has acquired Season Health
Des Moines, Iowa-based OpenLoop works behind the scenes of telehealth businesses to provide clinicians who can see patients and write prescriptions, handle shipping to pharmacies. Season Health connects patients to dietitians and allows them to order healthy meals from its marketplace.
AI meets GLP-1s
A post on X reads: "This story is ostensibly about how effective AI is at running a business, but I think it's probably more about how offering GLP-1s via telehealth is such a gangbusters business you literally can't NOT make money doing it"
Of course, we saw the viral New York Times story about how telehealth GLP-1 provider MEDVi was built almost entirely by one person (and his brother) and using AI. There are plenty of takes you can find swirling around on social media. This one reminded us of a recurring conversation the team has whenever we get overwhelmed trying to map out the many online providers of weight loss medications.
This week in health Тech
CMS released its 2027 Medicare Advantage payment rates on Monday, projecting a net increase of 2.5%. That’s up from the 0.9% rate increase proposed in January, but less than the 5% increase for 2026. Health insurers including Humana, UnitedHealth Group and CVS Health jumped in after-hours trading Monday on the news.
Teladoc Health faces demands from an activist investor. Frustrated by the telehealth giant's slumping shares since pandemic-era peaks, Pineal Capital Management wrote an open letter to Teladoc that included a demand to consider breaking off its therapy business BetterHelp to boost its stock price.

Primary care provider Marathon Health named Chris Pricco, a former COO within Optum, as its new CEO. Marathon co-founder Jeff Wells will remain on the company’s board. 

Insight Health, which handles administrative work like patient intake, screening and processing referrals using text and voice AI, raised $11 million. Standard Capital led the Series A round.

Yuzu Health, a third-party administrator, raised $35 million. General Catalyst and Chemistry led the Series A round. Anthropic's Anthology Fund also participated.
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin
Worldwide made. Thanks for reading.
Unsubscribe preferences
Unsubscribe from all newsletters
FT Specialist Logo A service from the Financial Times